A carregar...
Inhibiting HTLV-1 Protease: A Viable Antiviral Target
Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that can cause severe paralytic neurologic disease and immune disorders as well as cancer. An estimated 20 million people worldwide are infected with HTLV-1, with prevalence reaching 30% in some parts of the world. In stark contrast to...
Na minha lista:
| Publicado no: | ACS Chem Biol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8126997/ https://ncbi.nlm.nih.gov/pubmed/33619959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.0c00975 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|